Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,890,444 papers from all fields of science
Search
Sign In
Create Free Account
12 HR Treprostinil 2.5 MG Extended Release Oral Tablet
Known as:
treprostinil 2.5 MG 12HR Extended Release Oral Tablet
, TREPROSTINIL DIOLAMINE 2.5MG SA TAB
, TREPROSTINIL DIOLAMINE 2.5MG TAB,SA [VA Product]
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Decreased Blood Pressure [PE]
Extended Release Oral Tablet
Hypersensitivity
Prostaglandins I
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Orotracheal treprostinil administration attenuates bleomycin-induced lung injury, vascular remodeling, and fibrosis in mice
I. Nikitopoulou
,
N. Manitsopoulos
,
+8 authors
S. Orfanos
Pulmonary Circulation
2019
Corpus ID: 204051122
Pulmonary fibrosis is a progressive disease characterized by disruption of lung architecture and deregulation of the pulmonary…
Expand
2017
2017
Inhalation of dry powder INS1009 (DP-INS1009) does not activate the cough reflex in guinea pigs: a comparison with nebulized treprostinil
M. Corboz
,
R. Chapman
,
+8 authors
Zhili Li
2017
Corpus ID: 79530896
2016
2016
Treprostinil Iontophoresis Improves Digital Blood Flow during Local Cooling in Systemic Sclerosis
F. Gaillard-Bigot
,
M. Roustit
,
+5 authors
J. Cracowski
Microcirculation
2016
Corpus ID: 8463424
Severe Raynaud's syndrome and DUs are the most prevalent manifestations of SSc peripheral microvascular disease. We tested…
Expand
Review
2015
Review
2015
Treprostinil Iontophoresis in Idiopathic Pulmonary Arterial Hypertension.
A. Tonelli
,
Mostafa K. Ahmed
,
Laith Alkukhun
,
F. Cikach
,
K. Aulak
,
R. Dweik
American Journal of Respiratory and Critical Care…
2015
Corpus ID: 1634669
Idiopathic pulmonary arterial hypertension (PAH) is a progressive disease without identifiable etiology and is characterized by…
Expand
2013
2013
Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion
Ami A. Shah
,
E. Schiopu
,
+8 authors
K. Rollins
Arthritis Research & Therapy
2013
Corpus ID: 15032852
IntroductionTreprostinil diethanolamine is an innovative salt form of the prostacyclin analogue, treprostinil sodium, developed…
Expand
2013
2013
In vitro delivery of aerosolized treprostinil via modern mechanical ventilation.
Rajeev B. Patel
,
G. Smaldone
,
A. Cuccia
,
P. Strachan
Journal of Aerosol Medicine
2013
Corpus ID: 17314235
BACKGROUND The Tyvaso Inhalation System is a hand-held nebulizer system used to administer treprostinil, an approved therapy for…
Expand
Review
2012
Review
2012
Inhaled treprostinil: a therapeutic review
R. Channick
,
R. Voswinckel
,
L. Rubin
Drug Design, Development and Therapy
2012
Corpus ID: 12152219
Pulmonary arterial hypertension (PAH) is a life-threatening disease which, if untreated, leads to right ventricular failure and…
Expand
2011
2011
An Evaluation Of The Pharmacokinetics And Safety Of A Single Dose Of UT-15C SR (Treprostinil Diethanolamine) In Subjects With Hepatic Impairment Compared With Healthy Volunteers
L. Peterson
,
T. Marbury
,
K. Laliberte
Asian Test Symposium
2011
Corpus ID: 75495511
2009
2009
Verfahren zur herstellung von treprostinil-monohydrat und seine verwendung zur lagerung und zum transport
David A. Walsh
2009
Corpus ID: 133179696
Review
2008
Review
2008
Treprostinil NDA accepted for review by US FDA
2008
Corpus ID: 195105008
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE